ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe ...
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countriesDublin-based subsidiary to support ImmunityBio’s distribution and ...
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) ...
On 25–26 February 2026, African ministers responsible for trade will gather in Maputo, Republic of Mozambique, under the African Union (AU) framework. This meeting comes just weeks before the ...
Opinion - About 40 years ago, the now Senior Senator of Lofa County and Counsellor-At-Law, Joseph K. Jallah in 1986 was held for Contempt of Court by the Supreme Court of Liberia. Can we look at the ...
Approximately thirty million Kurds live in the Middle East, primarily in Iran, Iraq, Syria, and Turkey. In Turkey, Kurds comprise nearly one-fifth of the population. The Kurdistan Workers’ Party (PKK) ...
Streamlining of selected non‑strategic early-stage programs completed, consistent with previously announced three-year 2026-2028 strategic planNo ...
Matador Announces Intention to Spinout its Gold Treasury Platform, GODL Corp., into a Public Company
Matador has recently expanded its global footprint by investing in HODL Systems, one of India’s first digital asset treasury ...
V Ten Capital Corp. (TSXV: VTEN.P) ("VTen" or the "Company") is pleased to announce that, further to its previous announcements dated ...
Australian graphite producer Syrah Resources has signed a multi-year binding conditional offtake agreement with Canada’s NextSource Materials for the supply of natural graphite fines from its Balama ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results